IWA
ALDX icon

Inspirion Wealth Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Inspirion Wealth Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3K Hold
10,000
– – ﹤0.01% 187
2026
Q1 		$16.9K Hold
10,000
– – ﹤0.01% 180
2025
Q4 		$51.8K Buy
+10,000
New +$51.4K 0.01% 168
2025
Q3 		– Sell
-10,000
Closed -$38.3K – 152
2025
Q2 		$38.3K Buy
+10,000
New +$25.9K 0.01% 157

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Inspirion Wealth Advisors's ALDX Position: Q2 2026 in Review

Inspirion Wealth Advisors held its Aldeyra Therapeutics (ALDX) position steady in Q2 2026 at 10,000 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #187.

Inspirion Wealth Advisors first reported a position in ALDX in Q2 2025 and has held it in 4 quarters since. The position peaked at $51.8K in Q4 2025. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Inspirion Wealth Advisors held 10,000 shares of Aldeyra Therapeutics worth $24.3K as of Q2 2026.
  • Inspirion Wealth Advisors left its Aldeyra Therapeutics share count unchanged in Q2 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of Inspirion Wealth Advisors's portfolio in Q2 2026, its #187 holding.
  • Inspirion Wealth Advisors first reported a position in Aldeyra Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Inspirion Wealth Advisors's Aldeyra Therapeutics position peaked at $51.8K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Inspirion Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.